Jeffrey Alan Wolf - Dec 30, 2021 Form 4 Insider Report for HEAT BIOLOGICS, INC. (NHWK)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey Alan Wolf
Stock symbol
NHWK
Transactions as of
Dec 30, 2021
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 04:18 PM
Previous filing
Dec 27, 2021
Next filing
Dec 9, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHWK Stock Option (right to buy) Other $0 -232K -100% $0.00* 0 Dec 30, 2021 Common Stock 232K $4.07 Direct F1
transaction NHWK Stock Option (right to buy) Award $0 +232K $0.00 232K Dec 30, 2021 Common Stock 232K $4.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 28, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Wolf on December 13, 2021 covering 231,987 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
F2 The stock options to purchase 231,987 shares of Common Stock vest on the two-year anniversary of the date of grant, subject to the reporting person's continued service to the Company and is subject to forfeiture under certain circumstances.